Biopharma Industry Continues to Address Inequality, Inequity in the Life Sciences

Diversity has been a buzzword within the biopharma industry for the past several years as companies and organizations strive to bring in more voices at the corporate level, as well as within clinical trials themselves. But, there is still a long way to go, especially with companies helmed by minorities.